Cannabis use and genetic predisposition for schizophrenia: a case-control study

Area of Science:

• Psychiatry
• Genetics
• Epidemiology

Background:

• Cannabis use is a potential risk factor for schizophrenia.
• The association between cannabis and schizophrenia may involve genotype-environment interaction and correlation.
• Genotype-environment correlation in this context has not been previously explored.

Purpose of the Study:

• To investigate the association between cannabis use and schizophrenia.
• To determine if gene-environment correlation contributes to the cannabis-schizophrenia association.
• To examine cannabis use prevalence across varying genetic predispositions for schizophrenia.

Main Methods:

• A case-control study involving first-episode schizophrenia patients (cases) and two control groups (siblings and general hospital controls).
• Participants were non-Western immigrants in The Hague, Netherlands, from October 2000 to July 2005.
• Conditional logistic regression analyses were used to assess the relationship between cannabis use, schizophrenia, and genetic predisposition.

Main Results:

• Cases with schizophrenia reported significantly higher cannabis use (59%) compared to siblings (21%) and general hospital controls (21%).
• Cannabis use was a significant predictor of schizophrenia (OR 7.8-15.9).
• Genetic predisposition for schizophrenia did not predict cannabis use (OR 1.2).

Conclusions:

• Cannabis use is associated with schizophrenia.
• The study found no evidence to support a gene-environment correlation in the relationship between cannabis use and schizophrenia.
• Findings suggest that while cannabis use is a risk factor, genetic predisposition does not drive cannabis use in this population.